OncoCyte
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. OncoCyte's past years’ income statements indicate that its last revenue has increased compared to the previous period by 57% to $1,503,000. The net income raised on -$27,781,000 and profit margin reached -1848%. Total operating expenses were $25,637,000.
Profit Margin
| 2014 | 0 | -4.98M | |
|---|---|---|---|
| 2015 | 0 | -8.73M | |
| 2016 | 0 | -11.16M | |
| 2017 | 0 | -19.37M | |
| 2018 | 0 | -15.75M | |
| 2019 | 0 | -22.32M | |
| 2020 | 1.21M | -29.93M | -2461.51% |
| 2021 | 7.72M | -64.09M | -829.52% |
| 2022 | 958K | -73.44M | -7665.97% |
| 2023 | 1.50M | -27.78M | -1848.37% |
0KCC.L Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 1.50M | 958K | 7.72M | 1.21M | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 1.09M | 976K | 7.53M | 1.85M | 344K | 559K | 580K | 387K | 283K | 0 |
Gross profit | 413K | -18K | 188K | -639K | -344K | -559K | -580K | -387K | -283K | 0 |
Operating exp. | ||||||||||
Research and development | 9.29M | 7.30M | 13.63M | 9.8M | 6.79M | 6.51M | 7.17M | 5.67M | 4.52M | 3.96M |
Selling and marketing | 2.79M | 1.13M | 11.16M | 6.49M | 2.16M | 1.68M | 2.44M | 1.19M | 324K | 0 |
Total operating expenses | 25.63M | 30.31M | 47.13M | 33.08M | 22.23M | 15.20M | 18.84M | 11.14M | 8.71M | 4.97M |
Operating income | -25.13M | -17.99M | -46.94M | -29.71M | -22.23M | -15.20M | -18.84M | -11.14M | -8.71M | -4.97M |
Other income (expenses), net | 281K | -615K | -26.41M | -1.47M | -187K | -336K | -526K | -28K | -17K | -13K |
Income before tax | -24.85M | -18.61M | -73.35M | -31.18M | -22.42M | -15.75M | -19.37M | -11.16M | -8.73M | -4.98M |
Income tax expense | 0 | 54.82M | -9.26M | -1.25M | -97K | -336K | 217K | -387K | -262K | -9K |
Net income | -27.78M | -73.44M | -64.09M | -29.93M | -22.32M | -15.75M | -19.37M | -11.16M | -8.73M | -4.98M |
Earnings per share | ||||||||||
Basic EPS | -3.75 | -13.26 | -14.42 | -9.14 | -8.71 | -8.32 | -12.83 | -8.42 | -8.32 | -15.36 |
Diluted EPS | -3.75 | -13.26 | -14.42 | -9.14 | -8.71 | -8.32 | -12.83 | -8.42 | -8.32 | -15.36 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |